Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate
- PMID: 16959615
- DOI: 10.1016/j.ccr.2006.08.009
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate
Abstract
Reactive oxygen species (ROS) stimulate cell proliferation and induce genetic instability, and their increase in cancer cells is often viewed as an adverse event. Here, we show that such abnormal increases in ROS can be exploited to selectively kill cancer cells using beta-phenylethyl isothiocyanate (PEITC). Oncogenic transformation of ovarian epithelial cells with H-Ras(V12) or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC, which effectively disables the glutathione antioxidant system and causes severe ROS accumulation preferentially in the transformed cells due to their active ROS output. Excessive ROS causes oxidative mitochondrial damage, inactivation of redox-sensitive molecules, and massive cell death. In vivo, PEITC exhibits therapeutic activity and prolongs animal survival.
Comment in
-
Reactive oxygen species in cancer cells: live by the sword, die by the sword.Cancer Cell. 2006 Sep;10(3):175-6. doi: 10.1016/j.ccr.2006.08.015. Cancer Cell. 2006. PMID: 16959608
Similar articles
-
Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound.Cancer Biol Ther. 2007 May;6(5):646-7. doi: 10.4161/cbt.6.5.4092. Epub 2007 Mar 1. Cancer Biol Ther. 2007. PMID: 17387274 Review.
-
FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death.Anticancer Drugs. 2010 Oct;21(9):831-40. doi: 10.1097/CAD.0b013e32833ddba6. Anticancer Drugs. 2010. PMID: 20700043
-
15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.Clin Cancer Res. 2009 Sep 1;15(17):5414-25. doi: 10.1158/1078-0432.CCR-08-3101. Epub 2009 Aug 18. Clin Cancer Res. 2009. PMID: 19690198
-
Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.Clin Cancer Res. 2009 Mar 1;15(5):1686-97. doi: 10.1158/1078-0432.CCR-08-2141. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240172
-
ROS stress in cancer cells and therapeutic implications.Drug Resist Updat. 2004 Apr;7(2):97-110. doi: 10.1016/j.drup.2004.01.004. Drug Resist Updat. 2004. PMID: 15158766 Review.
Cited by
-
Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.Cell Stress Chaperones. 2012 Sep;17(5):529-38. doi: 10.1007/s12192-012-0329-3. Epub 2012 Feb 17. Cell Stress Chaperones. 2012. PMID: 22351438 Free PMC article.
-
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.Nature. 2013 Apr 4;496(7443):101-5. doi: 10.1038/nature12040. Epub 2013 Mar 27. Nature. 2013. PMID: 23535601 Free PMC article.
-
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.Breast Cancer Res Treat. 2012 Feb;132(1):215-23. doi: 10.1007/s10549-011-1889-0. Epub 2011 Dec 3. Breast Cancer Res Treat. 2012. PMID: 22138748 Free PMC article. Clinical Trial.
-
Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis.PLoS One. 2012;7(5):e37231. doi: 10.1371/journal.pone.0037231. Epub 2012 May 18. PLoS One. 2012. PMID: 22623999 Free PMC article.
-
Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer.Mol Ther. 2021 Feb 3;29(2):775-787. doi: 10.1016/j.ymthe.2020.10.016. Epub 2020 Oct 20. Mol Ther. 2021. PMID: 33091613 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous